Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TPO
DRUG
2 trials
Sponsors
Jinling Hospital, China
, Shenyang Sunshine Pharmaceutical Co., LTD.
Conditions
ITP
Sepsis
Thrombocytopenia
Phase 2
rhTPO in Critical Patients With Thrombocytopenia
NCT02094248
Jinling Hospital, China
Sepsis, Thrombocytopenia
Start: 2014-03-31
End: 2016-04-30
Target: 600
Updated: 2015-05-21
Phase 4
Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
Completed
NCT04089267
Shenyang Sunshine Pharmaceutical Co., LTD.
ITP
Start: 2016-12-31
End: 2019-08-31
Updated: 2019-09-13
Related Papers
Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial.
2015-05-19
5 citations